Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
4,972,209
-
Share change
-
-403,335
-
Total reported value
-
$9,851,950
-
Put/Call ratio
-
183%
-
Price per share
-
$1.98
-
Number of holders
-
40
-
Value change
-
-$780,397
-
Number of buys
-
16
-
Number of sells
-
19
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q3 2024
As of 30 Sep 2024,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,972,209 shares.
The largest 10 holders included
Tejara Capital Ltd, AdvisorShares Investments LLC, MMCAP International Inc. SPC, Lion Street Advisors, LLC, Foundations Investment Advisors, LLC, Knoll Capital Management, LLC, MGO ONE SEVEN LLC, MORGAN STANLEY, Cambridge Investment Research Advisors, Inc., and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.